Skip to main content

Table 3 Frequency of MACE and MACE components in the model development cohort

From: Development of a predictive model for major adverse cardiac events in a coronary artery bypass and valve population

Variable   All Procedures CABG AVR/MVR/MVrpr CABG + Valve
   n=4270 n=3095 n=696 n=479
   (%) (%) (%) (%)
MACE*   15.7 13.0 14.0 32.0
Mortality   4.2 3.3 3.3 11.5
Acute renal failure   6.5 5.5 5.5 14.0
Any stroke   2.9 2.3 2.4 7.3
  Transient (<24 h) 1.7 0.9 1.2 3.1
  Permanent 1.7 1.4 1.3 4.2
Infection   8.0 7.1 6.3 16.1
  Deep sternal Wound infection 1.1 1.0 0.1 2.9
  Sepsis 2.8 2.4 1.9 7.3
  Pneumonia 6.5 5.7 5.3 13.6
  1. *MACE—Major Adverse Cardiac Event defined as in-hospital death, stroke (persisting at discharge or transient), acute renal failure (new post-operative renal failure or acute on chronic (>50% increase from baseline creatinine)), or infection (sepsis, pneumonia, or deep sternal wound infection).